We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
(-43%)
Cap. Flow
-$786M
Cap. Flow
% of AUM
-52.7%
Top 10 Holdings %
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$10.5M |
| 2 |
iShares MSCI India ETF
INDA
|
+$9.67M |
| 3 |
IBKC
IBERIABANK Corp
IBKC
|
+$8.93M |
| 4 |
BlackRock Corporate High Yield Fund
HYT
|
+$8.03M |
| 5 |
Amazon
AMZN
|
+$7.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$16.7M |
| 2 |
Netflix
NFLX
|
+$15.8M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$15.7M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$15.1M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.31% |
| 2 | Consumer Discretionary | 3.94% |
| 3 | Healthcare | 3.91% |
| 4 | Communication Services | 2.7% |
| 5 | Financials | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATNX
726
DELISTED
Athenex, Inc. Common Stock
ATNX
| $56K | ﹤0.01% |
365
-1,362
| -79% | -$343K |
|
|
GSS
727
DELISTED
Golden Star Resources Ltd.
GSS
| $56K | ﹤0.01% |
+22,532
| New | +$65.1K |
|
|
COR
728
DELISTED
Coresite Realty Corporation
COR
| $56K | ﹤0.01% |
+481
| New | +$53.6K |
|
|
ACB
729
CALL
Aurora Cannabis
ACB
$216M
| $55K | ﹤0.01% |
509
+146
| +40% | +$26.1K |
|
730
PUT
Gaotu Techedu
GOTU
$429M
| $55K | ﹤0.01% |
+1,300
| New | +$48K |
|
731
Helen of Troy
HELE
$682M
| $55K | ﹤0.01% |
+381
| New | +$64.6K |
|
732
Mativ Holdings
MATV
$706M
| $55K | ﹤0.01% |
1,992
-699
| -26% | -$23.4K |
|
733
Waste Management
WM
$90.7B
| $55K | ﹤0.01% |
598
-526
| -47% | -$60.3K |
|
|
ENDP
734
DELISTED
Endo International plc
ENDP
| $55K | ﹤0.01% |
+14,796
| New | +$74.9K |
|
|
WLL
735
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $55K | ﹤0.01% |
1,084
-383
| -26% | -$98.1K |
|
736
Novartis
NVS
$294B
| $54K | ﹤0.01% |
655
-10,800
| -94% | -$964K |
|
|
LMNX
737
DELISTED
Luminex Corp
LMNX
| $54K | ﹤0.01% |
1,970
-1,194
| -38% | -$29.3K |
|
|
RTN
738
DELISTED
Raytheon Company
RTN
| $54K | ﹤0.01% |
411
-333
| -45% | -$65.9K |
|
|
EVRI
739
CALL
DELISTED
Everi Holdings
EVRI
| $53K | ﹤0.01% |
+16,000
| New | +$163K |
|
|
EVRI
740
PUT
DELISTED
Everi Holdings
EVRI
| $53K | ﹤0.01% |
+16,000
| New | +$163K |
|
741
Synaptics
SYNA
$4.18B
| $53K | ﹤0.01% |
+920
| New | +$62.4K |
|
742
CALL
Caesars Entertainment
CZR
$6.06B
| $52K | ﹤0.01% |
3,600
-300
| -8% | -$14K |
|
743
DNOW Inc
DNOW
$3.01B
| $52K | ﹤0.01% |
10,097
-1,388
| -12% | -$12.5K |
|
744
First Hawaiian
FHB
$3.34B
| $52K | ﹤0.01% |
3,175
+2,366
| +292% | +$59.8K |
|
745
CALL
Johnson & Johnson
JNJ
$626B
| $52K | ﹤0.01% |
400
-18,500
| -98% | -$2.62M |
|
|
MRC
746
DELISTED
MRC Global
MRC
| $52K | ﹤0.01% |
12,162
+11,062
| +1,006% | +$104K |
|
747
CALL
ProShares UltraPro S&P 500
UPRO
$5.7B
| $52K | ﹤0.01% |
+3,800
| New | +$113K |
|
748
Lesaka Technologies
LSAK
$414M
| $51K | ﹤0.01% |
+17,453
| New | +$64.6K |
|
749
Dentsply Sirona
XRAY
$2.31B
| $51K | ﹤0.01% |
+1,316
| New | +$67.1K |
|
750
Baxter International
BAX
$14.3B
| $50K | ﹤0.01% |
610
-7,424
| -92% | -$641K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
MCM
CC
MB
Prelude Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.
- Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
- Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
- Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
- Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
- Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
- Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
- Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.
Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.